These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 16939549

  • 21. [Association between genetic polymorphism of tumor necrosis factor and chronic severe hepatitis B in patients].
    Li Z, Li HQ, Yan Y, Liu Y, Hao W, Niu JQ, Yin JM, Li H.
    Zhonghua Yi Xue Za Zhi; 2007 Aug 14; 87(30):2105-8. PubMed ID: 17988528
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
    Yilmaz S, Bayan K, Tüzün Y, Dursun M, Kaplan A, Ozmen S, Canoruç F, Akkuş Z.
    Int J Clin Pract; 2007 Mar 14; 61(3):438-43. PubMed ID: 17313611
    [Abstract] [Full Text] [Related]

  • 24. Markers of inflammation and atherosclerosis in Egyptian patients with systemic lupus erythematosus.
    Sabry AA, Elbasyouni SR, Kalil AM, Abdel-Rahim M, Mohsen T, Sleem A.
    Nephrology (Carlton); 2006 Aug 14; 11(4):329-35. PubMed ID: 16889573
    [Abstract] [Full Text] [Related]

  • 25. [The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease].
    Kwon JH, Park ST, Kim GD, You CR, Kim JD, Woo HY, Jang JW, Kim CW, Bae SH, Choi JY, Yoon SK.
    Korean J Hepatol; 2009 Mar 14; 15(1):59-69. PubMed ID: 19346786
    [Abstract] [Full Text] [Related]

  • 26. Lack of effect of tumor necrosis factor-alpha -308 G/A polymorphism on severity of liver fibrosis in Tunisian hepatitis C virus (HCV)-infected patients.
    Bouzgarrou N, Hassen E, Gabbouj S, Schvoerer E, Ben Mami N, Triki H, Chouchane L.
    Gastroenterol Clin Biol; 2010 Mar 14; 34(4-5):297-304. PubMed ID: 20537485
    [Abstract] [Full Text] [Related]

  • 27. Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis.
    Park MC, Chung SJ, Park YB, Lee SK.
    Scand J Rheumatol; 2008 Mar 14; 37(3):173-8. PubMed ID: 18465450
    [Abstract] [Full Text] [Related]

  • 28. Circulating level of large splice variants of tenascin-C is a marker of piecemeal necrosis activity in patients with chronic hepatitis C.
    Tanaka H, El-Karef A, Kaito M, Kinoshita N, Fujita N, Horiike S, Watanabe S, Yoshida T, Adachi Y.
    Liver Int; 2006 Apr 14; 26(3):311-8. PubMed ID: 16584393
    [Abstract] [Full Text] [Related]

  • 29. Cytochrome P450 activity mirrors nitric oxide levels in postoperative sepsis: predictive indicators of lethal outcome.
    Novotny AR, Emmanuel K, Maier S, Westerholt A, Weighardt H, Stadler J, Bartels H, Schwaiger M, Siewert JR, Holzmann B, Heidecke CD.
    Surgery; 2007 Mar 14; 141(3):376-84. PubMed ID: 17349850
    [Abstract] [Full Text] [Related]

  • 30. [Hypomethylation of TNF-alpha gene promoter in the patients with acute-on-chronic hepatitis B liver failure].
    Han LY, Guo ZY, Fan YC, Wang K.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct 14; 25(5):368-70. PubMed ID: 22338227
    [Abstract] [Full Text] [Related]

  • 31. [Changes of serum soluble P-selectin and tumor necrotic factor-alpha in patients with CMV induced acute coronary syndrome].
    Wang XM, Li Y, Huang C, Zhang RH, Guo HT, Chen H, Wang HC.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Jun 14; 19(2):149-51. PubMed ID: 16027783
    [Abstract] [Full Text] [Related]

  • 32. [Clinical usefulness of plasma activities of gelatinase (matrix metalloproteinase-2 and 9) in chronic liver disease].
    Kwon OS, Lim DY, Kwon KA, Chung MG, Park DK, Kim SS, Kim YS, Kwon SY, Koo YS, Kim YK, Choi DJ, Kim JH, Hwang YJ, Byun KS, Lee CH.
    Taehan Kan Hakhoe Chi; 2003 Sep 14; 9(3):222-30. PubMed ID: 14515040
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Profile, spectrum and significance of hepatitis B virus genotypes in chronic HBV-infected patients in Yunnan, China.
    You J, Sriplung H, Chongsuvivatwong V, Geater A, Zhuang L, Huang JH, Chen HY, Yu L, Tang BZ.
    Hepatobiliary Pancreat Dis Int; 2008 Jun 14; 7(3):271-9. PubMed ID: 18522881
    [Abstract] [Full Text] [Related]

  • 35. Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1--possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis.
    Flisiak R, Maxwell P, Prokopowicz D, Timms PM, Panasiuk A.
    Hepatogastroenterology; 2002 Jun 14; 49(47):1369-72. PubMed ID: 12239944
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cytokine--chemokine and apoptotic signatures in patients with hepatitis C.
    Neuman MG, Benhamou JP, Marcellin P, Valla D, Malkiewicz IM, Katz GG, Trepo C, Bourliere M, Cameron RG, Cohen L, Morgan M, Schmilovitz-Weiss H, Ben-Ari Z.
    Transl Res; 2007 Mar 14; 149(3):126-36. PubMed ID: 17320798
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis.
    Custro N, Carroccio A, Ganci A, Scafidi V, Campagna P, Di Prima L, Montalto G.
    Diabetes Metab; 2001 Sep 14; 27(4 Pt 1):476-81. PubMed ID: 11547221
    [Abstract] [Full Text] [Related]

  • 40. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL, Rosas-Camargo V, Vega-Vega O, Morales-Espinosa D, Mendez-Reguera A, Martínez-Tlahuel JL, Gamboa-Domínguez A, Arrieta O.
    Clin Oncol (R Coll Radiol); 2007 Apr 14; 19(3):197-203. PubMed ID: 17359907
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.